May 21, 2026
CENTOGENE is now offering a new NGS Panel area focus on Pediatric disorders. Combining pediatric-focused curation, advanced genomic technologies, and deep scientific expertise.
The new portfolio supports earlier and more informed diagnoses across a broad spectrum of pediatric conditions:
- Pediatric-Focused Portfolio: 14 Disease Areas
- NGS Panels State of the Art Update
- 87 New Disease Panels
- CentoGenome as Backbone Available for Selected Panels
Benefit From Our Expertise in Pediatrics
For the first time, CENTOGENE is offering a specific NGS Panel portfolio designed to support the diagnosis of early and childhood-onset disorders through comprehensive genetic testing across 14 disease areas.
- Backed by Scientific and Diagnostic Expertise
More than 12 recent scientific publications related to early-onset disorders. - Comprehensive Testing Approach
87 Dedicated sub-panels with genome based analysis for complex variants. - Advanced Variant Detection
Detection of repeat expansions, CNVs and non-coding variants. - Curated Genes included
43 diagnostic genes curated through CENTOGENE’s gene-disease relationship experts. - Advanced Genomic Insights
Newly reported clinically relevant non-coding genes (e.g. RNU4-2) included in genome-based panels. - Powered by CENTOGENE Biodatabank
Ethnically diverse biodatabank with over 1 million patient cases.
Discover our New CentoPediatric Portfolio
